1. Jounce Therapeutics, Inc.

    0 Comments Leave a Comment

    1-1 of 1
    1. Mentioned In 1 Articles

    2. Jounce Therapeutics Appoints Robert Iannone, M.D., M.S.C.E., to its Board of Directors

      Jounce Therapeutics Appoints Robert Iannone, M.D., M.S.C.E., to its Board of Directors
      CAMBRIDGE, Mass., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced the appointment of Robert Iannone, M.D., M.S.C.E., to its board of directors...
      Read Full Article
    3. 1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content